Evaluation of the Abdala vaccine began in Cuba

Friday, November 22, 2024

NEWS

Evaluation of the Abdala vaccine began in Cuba

Published on: September 13, 2024
12:03

Santiago de Cuba, Sep 13 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) is conducting the Baconao 2 clinical trial today in Santiago de Cuba, to evaluate the protection provided by the Abdala vaccine against new strains of SARS-CoV-2.

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.

Evaluation of the Abdala vaccine began in Cuba

Evaluation of the Abdala vaccine began in Cuba

LATEST NEWS